Stockholm, Sweden

Athera Biotechnologies Ab


USPTO Granted Patents = 8



Forward Citations = 22

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Johan Frostegård (5 out of 12 patents)

silverMedal Andrew Nixon (2 out of 22 patents)

bronzeMedal Ulf De Faire (2 out of 2 patents)

4 Knut Pettersson (2 out of 9 patents)

5 Ola Camber (2 out of 4 patents)

6 Dan Sexton (2 out of 2 patents)

7 Johan Frostegärd (1 out of 1 patent)

8 Anna Frostegård (1 patent)

9 Andrew E Nixon (0 patent)

10 Nancy Pedersen (0 patent)

11 Knut Pettersson (0 patent)

12 Ola Camber (0 patent)

13 Andrew E Nixon (0 patent)

14 Johan Frostegard (0 patent)

15 Ulf De Faire (0 patent)


8 patents:

Athera Biotechnologies Ab is a Swedish biopharmaceutical company focused on the development of innovative therapeutics for the treatment of cardiovascular and inflammatory diseases. Their lead product candidate is a novel antibody targeting a specific protein linked to atherosclerosis and heart disease. Athera is committed to advancing scientific research and improving patient outcomes in areas of high unmet medical need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

8 Patents

#94 in Stockholm

#684 in Sweden

...
Stockholm, Sweden
Forward Citations = 22

23 inventors:

Please report any incorrect information to support@idiyas.com
Loading…